Thirty‐day readmissions after atrial fibrillation catheter ablation in patients with heart failure

• DOI: 10.1111/pace.14013
• Publication Date: 2020-07-21T12:24:59Z
• Authors: Fabio V. Lima; Kevin F. Kennedy; Wasiq Sheikh; Amy French; Anshul Parulkar; Esseim Sharma; Shady Henien; Michael Wu; Antony Chu
• Keywords: Adult; Aged, 80 and over; Heart Failure; Male; Middle Aged; Patient Readmission; United States; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Atrial Fibrillation; Catheter Ablation; Quality of Life; Humans; Female; Aged

Abstract Background Randomized clinical trial data have demonstrated catheter ablation (CA) as a viable treatment modality for atrial fibrillation (AF). Patients with heart failure (HF) undergoing AF CA appear to derive improvements in quality of life and mortality compared those treated medical therapy (MT). Contemporary national on 30‐day readmissions after MT among patients HF are lacking. Methods From the 2016 Nationwide Readmissions Databases, 749 776 (weighted estimate: 1 421 673) were identified which 2204 (0.3%) underwent 747 572 (99.7%) received MT. Propensity matching balanced baseline characteristics. Thirty‐day readmission rates, causes, predictors, costs compared. Results Among both unmatched matched cohorts, lower (16.8% vs 20.1%, P < .001 16.8% 18.8%, = .020). was associated reduced risk (odds ratio 0.86, 95% confidence interval [CI]: 0.77‐0.97). exacerbation arrhythmias most common cause CA. higher during index hospitalization but similar cohort ($15 858 ± $21 636 $16 505 $29 171, .67). Predictors largely nonmodifiable factors groups. Conclusions Nearly one six is readmitted within 30‐days In propensity analyses, decreased rate has costs, costs.